<- Back to digest

JOA - 2026-11-09 - Journal Article

Association of Enhanced Recovery After Surgery Protocol Utilization with Postoperative Delirium in Inpatient Total Joint Arthroplasty: A Retrospective Cohort Study.

Rowe JE, Giannakis P, Illescas A, Wang J, Cozowicz C, Liu J, Memtsoudis SG, Poeran J

retrospective cohortLOE IIIn = 1,169,017 (463,877 THA; 706,140 TKA)Index hospitalization plus 30 days postoperative.

Topics

arthroplasty
PMID: 43003365DOI: 10.1016/j.arth.2026.11.007View on PubMed ->

Key Takeaway

High ERAS utilization (>6 components) reduced postoperative delirium odds by 8% in THA (OR 0.92) but showed no significant association in TKA (OR 0.98) across a national cohort of 1,169,017 arthroplasties.

Summary Depth

Choose how much analysis to show on this article page.

Summary

This study examined whether ERAS protocol utilization—defined by eight operationalized components—was associated with reduced postoperative delirium incidence in inpatient primary THA and TKA using a national database from 2016–2023. Delirium incidence rose significantly over the study period in both cohorts (THA: 2.0% to 5.1%; TKA: 2.2% to 3.9%). High ERAS utilization was independently associated with reduced delirium in THA (OR 0.91–0.92) but not in TKA, with medium ERAS utilization conferring no benefit in either procedure.

Key Limitation

ERAS component ascertainment from administrative data cannot confirm actual bedside implementation, timing, or dosing fidelity, making it impossible to distinguish true protocol adherence from billing-code presence.

Original Abstract

INTRODUCTION

Postoperative delirium following total hip and knee arthroplasty (THA and TKA) is associated with worse outcomes. Enhanced recovery after surgery (ERAS) protocols may mitigate delirium risk, but this association has not been explored in THA and TKA. We evaluated the associations between ERAS utilization and postoperative delirium in inpatient TKA and THA.

METHODS

This retrospective cohort study used a national database to identify adult patients undergoing elective inpatient primary THA and TKA, respectively. Perioperative ERAS utilization was defined by eight components: multimodal analgesia, tranexamic acid, antiemetics, corticosteroids, physical therapy, avoidance of urinary catheters, avoidance of patient-controlled analgesia, and avoidance of wound drains. The ERAS implementation was operationalized as both a binary and a three-level categorical variable. The primary outcome was any delirium during the index hospitalization or within 30 days after index hospitalization. Mixed-effects models estimated adjusted odds ratios (OR) and 95% confidence intervals (CI).

RESULTS

Among 463,877 THAs and 706,140 TKAs, delirium incidence increased from 2016 to 2023 (THA; 2.0 to 5.1%,

TKA

2.2 to 3.9%, P < 0.001). In binary models, utilization of greater than six ERAS components was associated with reduced delirium risk in THA (OR 0.92, 95% CI 0.88 to 0.96, P < 0.001), but not TKA (OR 0.98, 95% CI 0.95 to 1.02, P = 0.28). In categorical models for THA, high ERAS utilization was also associated with lower odds of delirium compared to low ERAS utilization (OR 0.91, 95% CI 0.85 to 0.98, P = 0.01). Medium ERAS utilization was not associated with delirium odds compared to low.

CONCLUSIONS

In this national cohort study, higher ERAS utilization was associated with lower odds of postoperative delirium following THA, but not TKA. While the effect size was modest, these findings provide large-scale observational evidence of an association between ERAS utilization and postoperative delirium in THA.